• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆中抗肿瘤药物1,2:5,6-二脱水半乳糖醇的气相色谱分析。

Gas-chromatographic analysis for 1,2:5,6-dianhydrogalactitol, an anti-neoplastic agent, in plasma.

作者信息

Kimura T, Sternson L A, Higuchi T

出版信息

Clin Chem. 1976 Oct;22(10):1639-43.

PMID:975510
Abstract

We describe a gas chromatographic method for measuring submicrogram quantities of dianhydrogalactitol, a promising antineoplastic agent (currently undergoing clinical trials in humans), in plasma. The drug is first extracted from blood plasma by saturating the aqueous phase with solid potassium carbonate and extracting with isopropanol/chloroform (9/1 by vol). It is then converted to the corresponding n-butaneboronic ester by reaction at room temperature with butaneboronic acid and chromatographed on an SE-30 (3%) column, with flame ionization detection. Practicality of the method for monitoring drug distribution was demonstrated by administering dianhydrogalactitol in therapeutic doses to a dog and monitoring its concentrations in blood for the next 2 h.

摘要

我们描述了一种气相色谱法,用于测定血浆中亚微克量的双脱水半乳糖醇(一种有前景的抗肿瘤药物,目前正在进行人体临床试验)。首先通过用固体碳酸钾使水相饱和并用异丙醇/氯仿(体积比9/1)萃取,从血浆中提取该药物。然后在室温下使其与丁硼酸反应转化为相应的正丁硼酸酯,并在配备火焰离子化检测器的SE - 30(3%)柱上进行色谱分析。通过给一只狗施用治疗剂量的双脱水半乳糖醇并在接下来的2小时内监测其血液浓度,证明了该方法在监测药物分布方面的实用性。

相似文献

1
Gas-chromatographic analysis for 1,2:5,6-dianhydrogalactitol, an anti-neoplastic agent, in plasma.血浆中抗肿瘤药物1,2:5,6-二脱水半乳糖醇的气相色谱分析。
Clin Chem. 1976 Oct;22(10):1639-43.
2
High-performance liquid chromatographic analysis of dianhydrogalactitol in plasma by derivatization with sodium diethyldithiocarbamate.
J Chromatogr. 1977 Jul 1;143(4):375-82. doi: 10.1016/s0378-4347(00)80983-4.
3
A preliminary Pharmacokinetic study of dianhydrogalactitol (NSC-132313) disposition in the dog.二去水半乳糖醇(NSC-132313)在犬体内处置的初步药代动力学研究。
J Natl Cancer Inst. 1977 May;58(5):1311-4. doi: 10.1093/jnci/58.5.1311.
4
Phase I evaluation of dianhydrogalactitol (NSC-132313).双脱水半乳糖醇(NSC - 132313)的I期评估
Cancer Treat Rep. 1976 May;60(5):611-4.
5
Phase II study of dianhydrogalactitol and ICRF-159 in patients with advanced breast cancer previously exposed to cytotoxic chemotherapy.双去水半乳糖醇与ICRF-159治疗既往接受过细胞毒性化疗的晚期乳腺癌患者的II期研究。
Cancer Treat Rep. 1977 Jan-Feb;61(1):81-2.
6
Phase II study of VP-16-213 versus dianhydrogalactitol in patients with metastatic malignant melanoma.VP-16-213与双去水半乳糖醇治疗转移性恶性黑色素瘤患者的II期研究。
Cancer Treat Rep. 1976 Nov;60(11):1681-2.
7
Phase II studies of dianhydrogalactitol and VP-16-213 in colorectal cancer.双去水半乳糖醇与依托泊苷(VP-16-213)用于结直肠癌的II期研究。
Cancer Treat Rep. 1976 Sep;60(9):1247-50.
8
Phase I trial of dianhydrogalactitol administered Iv in a weekly schedule.以每周一次的给药方案静脉注射去水卫矛醇的I期试验。
Cancer Treat Rep. 1976 Jul;60(7):895-901.
9
Studies on the distribution of dianhydrogalactitol into the central nervous system of the rat.二去水半乳糖醇在大鼠中枢神经系统中的分布研究。
Cancer Treat Rep. 1978 Mar;62(3):409-12.
10
1,2:5,6-Dianhydrogalactitol in advanced breast cancer.1,2:5,6-二脱水半乳糖醇用于晚期乳腺癌
Cancer Treat Rep. 1978 May;62(5):841-2.

引用本文的文献

1
Pharmacokinetic study in a phase I trial with an alkylating agent, diacetyldianhydrogalactitol (DADAG).一项关于烷化剂双乙酰双去水半乳糖醇(DADAG)的I期试验的药代动力学研究。
Cancer Chemother Pharmacol. 1986;16(3):257-63. doi: 10.1007/BF00293988.